- $756.03m
- $4.67bn
- $1.29bn
- 47
- 74
- 81
- 75
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,587 | 4,728 | 4,389 | 1,601 | 1,289 |
Cost of Revenue | |||||
Gross Profit | 1,322 | 4,390 | 3,878 | 1,276 | 1,064 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,394 | 2,380 | 3,197 | 1,973 | 1,205 |
Operating Profit | 194 | 2,348 | 1,192 | -372 | 83.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 32.7 | 2,015 | 667 | -690 | -278 |
Provision for Income Taxes | |||||
Net Income After Taxes | 34.4 | 2,013 | 623 | -610 | -236 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 0 | 0 | 114 | -273 | -110 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0 | 0 | 114 | -273 | -110 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0 | 0.008 | 0.917 | -1.5 | -0.583 |
Dividends per Share | |||||
Special Dividends per Share |